drugset / Trial / NCT07488897
RIG 101 Trial in Healthy Adults and Adults With Asthma
Phase 1/2
Recruiting
82 enrolled
RIGImmune Inc.
Medicines Evaluation Unit Ltd · collabVirTus Respiratory Research Ltd · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Nested Phase 1-2 Trial of RIG-101 in Healthy and Asthmatic Participants Assessing Safety, Tolerability and Viral Challenge Efficacy
Timeline
- Start
- 2026-02-09
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RIG-101 | Unknown | — | Intranasal |